JLK Technology

JLK is a South Korean medical artificial intelligence company that specializes in developing AI-driven diagnostic solutions for a wide range of medical conditions. The company's core platform, AIHuB, integrates over 30 different AI models to analyze medical imaging data from MRI, CT, and X-ray scans. JLK is particularly renowned for its stroke diagnostic suite, which includes the JBS-01K solution for ischemic stroke detection, designed to assist physicians in making rapid, life-saving decisions. In addition to neurology, the company provides AI tools for oncology, including prostate and lung cancer screening, and neurodegenerative diseases like Alzheimer's. As the first AI medical company to list on the KOSDAQ, JLK has established a global presence with numerous regulatory clearances and strategic partnerships with major technology firms like Intel and Microsoft.